September 01, 2014 3:42 AM ET

Pharmaceuticals

Company Overview of Peloton Therapeutics, Inc.

Company Overview

Peloton Therapeutics, Inc., an early-stage cancer drug discovery and development company, engages in the development of oncology drugs. The company was incorporated in 2010 and is based in Dallas, Texas.

2330 Inwood Road

Suite 226

Dallas, TX 75235-7323

United States

Founded in 2010

Phone:

972-629-4100

Key Executives for Peloton Therapeutics, Inc.

Acting Chief Executive Officer and Director
President and Chief Scientific officer
Age: 53
Founder and Director
Age: 73
Founder and SAB Chairman
Age: 64
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Drug Source Company, LLC United States
Drug Delivery System Inc. United States
Acupac Packaging, Inc. United States
UPM Pharmaceuticals, Inc. United States
Agrigenic Food Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Peloton Therapeutics, Inc., please visit www.pelotontherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.